The paradigm that DNA sensors incite immunity via STING/IFN-I signaling was also reinforced by reports showing that cyclic dinucleotides (CDNs), which bind and activate STING, incited robust anti-tumor immunity (4). This evidence concerns the gene STING1 and neoplasm.